Details for Patent: 5,358,970
✉ Email this page to a colleague
Summary for Patent: 5,358,970
Title: | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
Abstract: | This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year. |
Inventor(s): | Ruff; Michael D. (Greenville, NC), Kalidindi; Sanyasi R. (Edison, NJ), Sutton, Jr.; Joel E. (Greenville, NC) |
Assignee: | Burroughs Wellcome Co. (Research Triangle Park, NC) |
Application Number: | 08/105,437 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; Use; |
Drugs Protected by US Patent 5,358,970
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,358,970
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 232383 | ⤷ Subscribe | |||
Australia | 698883 | ⤷ Subscribe | |||
Australia | 7235294 | ⤷ Subscribe | |||
Canada | 2168364 | ⤷ Subscribe | |||
Germany | 69432121 | ⤷ Subscribe | |||
Denmark | 0711154 | ⤷ Subscribe | |||
European Patent Office | 0711154 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |